The Directorate General of Drug Administration (DGDA) is Bangladesh's national medicines regulatory authority and is responsible for post-market medicine-safety oversight.
Core official resource
- DGDA — national authority portal for medicines regulation, notices, safety information and pharmacovigilance-related material.
Verification note
Bangladesh's public pharmacovigilance material is not consistently exposed through one stable English-language operational page. This hub therefore does not state a current industry ICSR portal, reporting timeline, local-QPPV requirement or PSMF requirement unless a current DGDA source can be tied to the claim. Operational users should confirm the current DGDA pharmacovigilance contact and reporting mechanism before relying on a local SOP.